BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13843721)

  • 1. The clinical effects of iproniazid and similar compounds on the gastrointestinal tract.
    WEISS J; WEISS S; WEISS B
    Am J Gastroenterol; 1960 May; 33():592-9. PubMed ID: 13843721
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of iproniazid and similar compounds on the gastrointestinal tract.
    WEISS J; WEISS S; WEISS B
    Ann N Y Acad Sci; 1959 Sep; 80():854-9. PubMed ID: 13843720
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of iproniazid and 5-hydroxytryptophan on the 5-hydroxytryptamine content in the gastro-intestinal tract and thyroid gland of rats.
    PAASONEN MK; KARKI NT; MOLKKA S
    Ann Med Exp Biol Fenn; 1961; 39():405-10. PubMed ID: 14482989
    [No Abstract]   [Full Text] [Related]  

  • 4. THE INFLUENCE OF IPRONIAZID ON THE ABSORPTION FROM THE GASTRO-INTESTINAL TRACT IN RATS.
    LEIJNSE B; VAN PRAAGH
    Arch Int Pharmacodyn Ther; 1964 Aug; 150():582-90. PubMed ID: 14205402
    [No Abstract]   [Full Text] [Related]  

  • 5. Central effects of beta-phenylisopropylhydrazine and iproniazid.
    FURGIUELE AR; KINNARD WJ; BUCKLEY JP
    J Pharmacol Exp Ther; 1962 Sep; 137():356-60. PubMed ID: 13895937
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental pathology of iproniazid and related compounds.
    ZBINDEN G; STUDER A
    Ann N Y Acad Sci; 1959 Sep; 80():873-84. PubMed ID: 13847126
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of the effects of biogenic amines on the heart by iproniazid.
    BURFORD H; LEICK J; WALASZEK EJ
    Arch Int Pharmacodyn Ther; 1960 Oct; 128():39-50. PubMed ID: 13688979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of some thymo-analeptics on the excitability of nerve centers].
    CHAUCHARD P; MAZOUE H
    C R Seances Soc Biol Fil; 1962; 156():466-7. PubMed ID: 13878449
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of iproniazid and pyrogallol on the hermogenic effects of noradren aline.
    JOHNSON GE; SELLERS EA
    Can J Biochem Physiol; 1962 May; 40():631-8. PubMed ID: 14452037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution to the neurophysiological study of iproniazid].
    PLAS R; NAQUET R
    C R Seances Soc Biol Fil; 1961; 155():547-50. PubMed ID: 14487095
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of the hypothalamo-neurohypophysial neurosecretory system after iproniazid treatment.
    KIVALO E; RINNE UK
    Ann Med Exp Biol Fenn; 1961; 39():50-6. PubMed ID: 13756500
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of iproniazid on hypothalamic reactions to adrenaline].
    MINZ B; THUILLIER J
    C R Seances Soc Biol Fil; 1959; 153():962-5. PubMed ID: 14422809
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of iproniazid and other amine oxidase inhibitors.
    RANDALL LO; BAGDON RE
    Ann N Y Acad Sci; 1959 Sep; 80():626-42. PubMed ID: 14436140
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modification of the fever inducing effect of bacterial pyrogens by iproniazid, reserpine and dibenamine].
    GOEING H
    Arzneimittelforschung; 1959 Dec; 9():793-4. PubMed ID: 13850401
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of iproniazid on Tetrahymena pyriformis.
    KREZANOSKI JZ
    J Pharm Sci; 1961 May; 50():421-4. PubMed ID: 13754314
    [No Abstract]   [Full Text] [Related]  

  • 16. Some preliminary clinical and biochemical aspects of liver function in patients receiving iproniazid.
    ZIMMERMAN HJ; ROSENBLUM L; KORN RJ; FELDMAN PE
    Ann N Y Acad Sci; 1959 Sep; 80():915-27. PubMed ID: 13847532
    [No Abstract]   [Full Text] [Related]  

  • 17. Decrease in oxygen consumption of rats by chronic iproniazid treatment.
    SETNIKAR I; MURMANN W; MAGISTRETTI MJ
    Arch Int Pharmacodyn Ther; 1960 Dec; 129():172-90. PubMed ID: 13750385
    [No Abstract]   [Full Text] [Related]  

  • 18. Catecholamine levels of brain and heart in mice after iproniazid, syrosingopine and 10-methoxydeserpidine.
    LEROY JG; DE SCHAEPDRYVER AF
    Arch Int Pharmacodyn Ther; 1961 Feb; 130():231-4. PubMed ID: 13761108
    [No Abstract]   [Full Text] [Related]  

  • 19. Serial hepatic study in patients treated with iproniazid.
    KATZ R; KLINGER J; SILVA L; RODRIGUEZ J; DUCCI H
    Ann N Y Acad Sci; 1959 Sep; 80():898-914. PubMed ID: 14404815
    [No Abstract]   [Full Text] [Related]  

  • 20. Increase in resistance of the heart to anoxia by iproniazid.
    SETNIKAR I; RAVASI MT
    Arch Int Pharmacodyn Ther; 1960 Feb; 124():116-22. PubMed ID: 14445194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.